Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Rises By 279.3%

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOYGet Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 48,491 shares, an increase of 279.3% from the June 30th total of 12,783 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 388,731 shares, the short-interest ratio is currently 0.1 days.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. Zacks Research upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Finally, Jefferies Financial Group raised Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Two equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy”.

View Our Latest Stock Report on Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

Shares of SGIOY opened at $8.68 on Monday. The stock has a market capitalization of $14.77 billion, a P/E ratio of 10.85, a PEG ratio of 3.41 and a beta of 0.09. Shionogi & Co., Ltd. Unsponsored ADR has a twelve month low of $7.65 and a twelve month high of $12.00. The company has a quick ratio of 1.46, a current ratio of 1.58 and a debt-to-equity ratio of 0.01. The firm has a fifty day simple moving average of $8.86 and a two-hundred day simple moving average of $9.88.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOYGet Free Report) last released its quarterly earnings data on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03. The firm had revenue of $881.71 million for the quarter, compared to analysts’ expectations of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 13.56%. On average, research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.79 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

(Get Free Report)

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.

See Also

Receive News & Ratings for Shionogi & Co. Ltd. Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.